Martine A Rothblatt United Therapeutics Corp (UTHR) insider trading activity

Martine A Rothblatt is Chairperson & CEO of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 130 shares of UTHR, which is worth approximately $52,404. The most recent transaction as insider was on Jul 29, 2024, when has been sold 3,600 shares (Common Stock) at a price of $336.52 per share, resulting in proceeds of $1,211,472. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130

0% 3M change

0% 12M change

Total Value Held $52,404

MARTINE A ROTHBLATT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 29 2024	SELL Open market or private sale	$1,211,472 $336.52 p/Share	3,600 Reduced 96.51%	130 Common Stock
Jul 29 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Jul 26 2024	SELL Open market or private sale	$1,218,528 $338.48 p/Share	3,600 Reduced 96.51%	130 Common Stock
Jul 26 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Jul 25 2024	SELL Open market or private sale	$1,220,976 $339.16 p/Share	3,600 Reduced 96.51%	130 Common Stock
Jul 25 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Jul 24 2024	SELL Open market or private sale	$1,203,696 $334.36 p/Share	3,600 Reduced 96.51%	130 Common Stock
Jul 24 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Jul 23 2024	SELL Open market or private sale	$1,205,100 $334.75 p/Share	3,600 Reduced 96.51%	130 Common Stock
Jul 23 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Jul 22 2024	SELL Open market or private sale	$1,187,748 $329.93 p/Share	3,600 Reduced 96.51%	130 Common Stock
Jul 22 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Jul 19 2024	SELL Open market or private sale	$1,186,020 $329.45 p/Share	3,600 Reduced 96.51%	130 Common Stock
Jul 19 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Jul 18 2024	SELL Open market or private sale	$1,195,164 $331.99 p/Share	3,600 Reduced 96.51%	130 Common Stock
Jul 18 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Jul 17 2024	SELL Open market or private sale	$1,199,844 $333.29 p/Share	3,600 Reduced 96.51%	130 Common Stock
Jul 17 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Jul 16 2024	SELL Open market or private sale	$1,182,240 $328.4 p/Share	3,600 Reduced 96.51%	130 Common Stock
Jul 16 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Jul 15 2024	SELL Open market or private sale	$1,172,844 $325.79 p/Share	3,600 Reduced 96.51%	130 Common Stock
Jul 15 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Jul 12 2024	SELL Open market or private sale	$1,172,808 $325.78 p/Share	3,600 Reduced 96.51%	130 Common Stock
Jul 12 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Jul 11 2024	SELL Open market or private sale	$1,175,580 $326.55 p/Share	3,600 Reduced 96.51%	130 Common Stock

MAR

Martine A Rothblatt

Chairperson & CEO

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account